Biotech News
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
MASON, Ohio --(BUSINESS WIRE)--May 27, 2026-- AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating
